© 2004 European Society of Cardiology
Vagal heart rate responses to chronic beta-blockade in human heart failure relate to cardiac norepinephrine spillover
Division of Cardiology, Mount Sinai Hospital and University Health Network Department of Medicine University of Toronto, 600 University Avenue Suite 1614, Toronto, Ontario, Canada, M5G 1X5
* Corresponding author. Tel.: +1 416 586 8704; fax: +1 416 586 8702. E-mial address: john.floras{at}utoronto.ca
| Abstract |
|---|
We have documented a pre-junctional β-2 adrenoceptor mediated reduction in cardiac norepinephrine spillover (CNES) in heart failure patients receiving chronic β-blockade. Our present objective was to ascertain the consequence of this decrease for vagal heart rate (HR) regulation by determining CNES, arterial baroreflex sensitivity for HR (BRS) and arterial baroreflex modulation of muscle sympathetic nerve activity (MSNA) before and upon 4 months of β-blockade with either carvedilol or metoprolol. In 19 heart failure patients in sinus rhythm (age: 55±2 [mean±S.E.]; ejection fraction: 20±2%), β-blockade increased BRS from 4.8±0.9 to 7.9±1.3 ms/mm Hg (P<0.005) but had no effect on arterial baroreflex modulation of MSNA. Changes in CNES and BRS were inversely related (r=–0.52; n=16, P<0.05). Chronic β-blockade in heart failure augments reflex vagal control of HR at an efferent site of interaction involving blockade of cardiac sympathetic pre-junctional β-2 adrenoceptors that facilitate NE release.
Key Words: Adrenergic receptor blockers Autonomic nervous system Baroreflex Heart rate variability Receptors, adrenergic, beta Sympathetic nervous system
Received May 10, 2004; Revised August 4, 2004; Accepted October 14, 2004
1 Current address: Matsuyama Red Cross Hospital, Masuyama Ehime 790-0826, Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J. Am. Coll. Cardiol., November 3, 2009; 54(19): 1747 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. O. Tan, M. A. Cohen, D. L. Eckberg, and J. A. Taylor Fractal properties of human heart period variability: physiological and methodological implications J. Physiol., August 1, 2009; 587(15): 3929 - 3941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Floras Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 375 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Floras and S. Mak Muscle sympathetic nerve activity in women and men following acute myocardial infarction: a meaningful difference? Eur. Heart J., July 2, 2009; 30(14): 1692 - 1694. [Full Text] [PDF] |
||||
![]() |
M. T. La Rovere, G. D. Pinna, R. Maestri, E. Robbi, A. Caporotondi, G. Guazzotti, P. Sleight, and O. Febo Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J. Am. Coll. Cardiol., January 13, 2009; 53(2): 193 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olshansky, H. N. Sabbah, P. J. Hauptman, and W. S. Colucci Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy Circulation, August 19, 2008; 118(8): 863 - 871. [Full Text] [PDF] |
||||
![]() |
B. Geny, A. Charloux, G. Brandenberger, and F. Piquard Despite cardiac denervation, atrial natriuretic peptides possess a cardiac sympathoinhibitory effect after heart transplantation J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1417 - 1418. [Full Text] [PDF] |
||||




